BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma P, Tang WG, Hu JW, Hao Y, Xiong LK, Wang MM, Liu H, Bo WH, Yu KH. HSP4 triggers epithelial-mesenchymal transition and promotes motility capacities of hepatocellular carcinoma cells via activating AKT. Liver Int 2020;40:1211-23. [PMID: 32077551 DOI: 10.1111/liv.14410] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Puustinen MC, Sistonen L. Molecular Mechanisms of Heat Shock Factors in Cancer. Cells 2020;9:E1202. [PMID: 32408596 DOI: 10.3390/cells9051202] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
2 Wang F, Li L, Zhang Z. Platelet isoform of phosphofructokinase promotes aerobic glycolysis and the progression of non‑small cell lung cancer. Mol Med Rep 2021;23:74. [PMID: 33236133 DOI: 10.3892/mmr.2020.11712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Lin J, Cao Z, Yu D, Cai W. Identification of Transcription Factor-Related Gene Signature and Risk Score Model for Colon Adenocarcinoma. Front Genet 2021;12:709133. [PMID: 34603375 DOI: 10.3389/fgene.2021.709133] [Reference Citation Analysis]
4 Ding ZN, Dong ZR, Chen ZQ, Yang YF, Yan LJ, Li HC, Liu KX, Yao CY, Yan YC, Yang CC, Li T. Effects of hypoxia-inducible factor-1α and hypoxia-inducible factor-2α overexpression on hepatocellular carcinoma survival: A systematic review with meta-analysis. J Gastroenterol Hepatol 2021;36:1487-96. [PMID: 33393670 DOI: 10.1111/jgh.15395] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Guo F, Cheng X, Jing B, Wu H, Jin X. FGD3 binds with HSF4 to suppress p65 expression and inhibit pancreatic cancer progression. Oncogene 2022. [PMID: 34975151 DOI: 10.1038/s41388-021-02140-6] [Reference Citation Analysis]
6 Wang G, Cao P, Fan Y, Tan K. Emerging roles of HSF1 in cancer: Cellular and molecular episodes. Biochim Biophys Acta Rev Cancer 2020;1874:188390. [PMID: 32653364 DOI: 10.1016/j.bbcan.2020.188390] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Syafruddin SE, Ling S, Low TY, Mohtar MA. More Than Meets the Eye: Revisiting the Roles of Heat Shock Factor 4 in Health and Diseases. Biomolecules 2021;11:523. [PMID: 33807297 DOI: 10.3390/biom11040523] [Reference Citation Analysis]
8 Tian H, Zhu X, Lv Y, Jiao Y, Wang G. Glucometabolic Reprogramming in the Hepatocellular Carcinoma Microenvironment: Cause and Effect. Cancer Manag Res 2020;12:5957-74. [PMID: 32765096 DOI: 10.2147/CMAR.S258196] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
9 Zhang B, Huang L, Tu J, Wu T. Hypoxia-Induced Placenta-Specific microRNA (miR-512-3p) Promotes Hepatocellular Carcinoma Progression by Targeting Large Tumor Suppressor Kinase 2. Onco Targets Ther 2020;13:6073-83. [PMID: 32612368 DOI: 10.2147/OTT.S254612] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Shi X, Tu S, Zhu L. Risk characteristics with seven epithelial-mesenchymal transition-related genes are used to predict the prognosis of patients with hepatocellular carcinoma. J Gastrointest Oncol 2021;12:1884-94. [PMID: 34532136 DOI: 10.21037/jgo-21-394] [Reference Citation Analysis]